BIO P219 Body Scrub Study

Prescreening is required in the Bio Department. Come in any time of the day to prescreen. 

Study Description:  

Visit 1/Pick-Up & Baseline, panelists will report to ECRL with clean product free arms and legs. Inclusion and exclusion criteria will be verified and informed consent will be obtained. Subjects in group 1 will receive a questionnaire. Subjects in groups 2&3 will have clinical grading, Visioscan evaluations, professional photography taken and take a questionnaire. All subjects will receive a daily dairy, product, and soap. 

Visits 2-3: Subjects in group 1 will take an at home questionnaire for Visits 2 & 3 (no lab visits). Subjects in group 2&3 will have clinical grading, Visioscan evaluations, professional photography taken and take a questionnaire for each visit.  

Visits 4: Subjects in group 1 will return to ECRL for Visit 4 (final visit) to take a questionnaire and return their daily diary and product. Subjects in group 2&3 will have clinical grading, Visioscan evaluations, professional photography taken and take a questionnaire, and return their daily diary and product.  

Inclusion Criteria 

• Subject is female between the ages of 25-55 
• Subject agrees not to introduce any new cosmetic or toiletry products during the study; 
• Subjects have used body scrubs. 
• Subjects are self-perceived body acne prone. 
• Subjects have mild to moderate rough skin and uneven skin tone. 
• Subjects are users of sunscreen and agree to use their own sunscreen when in the sun for duration of the study. 
• Subject agrees to wear pants/shirts that allow easy access to the test sites: Back of shoulder/arm and calves; 

Exclusion Criteria 

• Subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control;  
• Subject has excessive hair, tattoos, scars that may interfere with the study evaluations. 
• Subject has received treatment with sympathomimetics, antihistamines, vasoconstrictors, non-steroidal anti-inflammatory agents, and/or systemic or topical corticosteroids within one week prior to initiation of the study;  
• Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would, in the opinion of the Principal Investigator, preclude application of the test material and/or could influence the outcome of the study;  
• Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study;  
• Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs;  
• Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind;  
• Subject has diabetes.  

Study Groups and Dates: 

Group 2

V1   Tues.       9/03      1.5 hrs.

V2   Thurs.    9/12        45 min.

V3   Tues.      9/17       45 min.

V4   Mon.      9/30      45 min.

Appointment times: 7:40am – 3:20pm 

Group 3

V1   Mon.       9/09      1.5 hrs.

V2   Mon.       9/16        45 min.

V3   Mon.      9/23       45 min.

V4   Mon.      10/07      45 min.

Appointment times: 7:40am – 3:20pm